<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
LOS ANGELES, Nov. 29, 2021 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Novavax, Inc. (“Novavax” or the “Company”) (NASDAQ: NVAX). Class Period: March 2, 2021 – October 19, 2021 Lead Plaintiff Deadline: January 11, 2022 If you wish to serve as lead plaintiff of the Novavax lawsuit, you can submit your contact information at www.glancylaw.com/cases/novavax-inc/.
...read full article on PRNewsWire
